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I. Experimental Details 
 
General considerations:  
Unless indicated otherwise, reactions performed under inert atmosphere were 
carried out in oven-dried glassware in a glovebox under a nitrogen atmosphere purified 
by circulation through RCI-DRI 13X-0408 Molecular Seives 13X, 4x8 Mesh Beads and 
BASF PuriStar® Catalyst R3-11G, 5x3 mm (Research Catalysts, Inc.). Solvents for all 
reactions were purified by Grubbs’ method.1 CD3CN and CD2Cl2 were purchased from 
Cambridge Isotope Laboratories and distilled from CaH2 prior to use. Alumina and Celite 
were activated by heating under vacuum at 200 °C for 24 hours. 1H, 19F, and 31P NMR 
spectra were recorded on Varian Mercury 300 MHz spectrometers at ambient 
temperature, unless denoted otherwise. 13C NMR spectra were recorded on a Varian 
INOVA-500 MHz spectrometer. 1H and 13C NMR chemical shifts are reported with 
respect to internal solvent: 1.94 ppm and 118.26 for CD3CN, and 5.32 ppm and 53.84 
ppm for CD2Cl2, respectively. 19F and 31P NMR chemical shifts are reported with respect 
to an external standard of C6F6 (-164.9 ppm) and 85% H3PO4 (0.0 ppm).  
Powder and thin film ATR-IR measurements were obtained by placing a powder 
or drop of solution of the complex on the surface of a Bruker APLHA ATR-IR 
spectrometer probe and allowing the solvent to evaporate (Platinum Sampling Module, 
diamond, OPUS software package) at 2 cm–1 resolution. Solution IR spectra were 
recorded on a Thermo-Fisher Scientific Nicolet 6700 FTIR spectrometer using a CaF2 
plate solution cell. Fast atom bombardment-mass spectrometry (FAB-MS) analysis was 
performed with a JEOL JMS-600H high-resolution mass spectrometer. Gas 
chromatography-mass spectrometry (GC-MS) analysis was performed upon filtering the 
sample through a plug of silica gel. Electrochemical measurements were recorded with a 
Pine Instrument Company AFCBP1 bipotentiostat using the AfterMath software package. 
Cyclic voltammograms and square-wave voltammograms were recorded on ca.  2 mM 
solutions of the relevant complex in the glovebox at 20 °C with an auxiliary Pt-coil 
electrode, a Ag/Ag+ reference electrode (0.01 M AgNO3, 0.1 M [nBu4N+][PF6-] in 
MeCN), and a 3.0 mm glassy carbon electrode disc (BASI). The electrolyte solution was 
0.1 M [nBu4N+][PF6-] in MeCN. All reported values are referenced to an internal 
ferrocene/ferrocenium couple. Elemental analysis was conducted by Robertson Microlit 
Labs (Ledgewood, NJ). 
Unless otherwise noted all chemical reagents were purchased from commercial 
sources and used without further purification. AgOTf, 2,3-dichloro-5,6-dicyano-1,4-
benzoquinone and benzo-15-crown-5 were purchased from Sigma Aldrich and used as 
received. 2,6-di-tert-butyl-4-methylpyridine, 4-tert-butylphenol, 2-nitroaniline, and 
[2,2,2]-diazobicyclooctane were purchased from Sigma Aldrich and sublimed prior to 
use. PhICl2,2 BnK,3 1,4 4,4 84, and Fetizon’s reagent (Ag2CO3 on Celite)5 were prepared 
using literature procedures. Assignments of NMR spectra are given corresponding to the 
following numbering scheme: 
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Synthesis of bis(benzo-15-crown-5)potassium [1,4-bis(2-
(diisopropylphosphino)phenyl)-2,3-semicatecholate]tricarbonylmolybdenum(0) (9) 
 
 
 
To a solution of 1 (0.0623 g, 0.0924 mmol) in THF (2 mL) was added dropwise a 
solution of BnK (0.0118 g, 0.0906 mmol) in THF (2 mL). Upon complete addition, a 
solution of benzo-15-crown-5 (0.0507 g, 0.189 mmol) in THF (2 mL) and the mixture 
was stirred at room temperature for 30 minutes. The volatiles were then removed under 
reduced pressure, and the resulting residue was triturated with Et2O (5 mL) and the solid 
collected on a pad of celite. The solid was then dissolved in benzene (5 mL), filtered 
through celite, and concentrated in vacuo to afford the desired product as an orange 
powder (0.0756 g, 66%). 1H NMR (300 MHz, CD3CN , 25 °C), δ(ppm): 9.22 (s, br, 1 H, 
O–H), 8.04 (d, 8 Hz, 2 H, Ar-CH), 7.91 (d, 8 Hz, 2 H, Ar-CH), 7.38 (t, 8 Hz, 2 H, Ar-
CH), 7.25 (t, 8 Hz, 2 H, Ar-CH), 6.91 (m, 2 H, crown Ar-CH), 6.81 (m, 2 H, crown Ar-
CH), 5.38 (t, 4.9 Hz, 2 H, quinonoid Ar-C3H), 3.91 (m, 4 H, crown O–CH2), 3.66 (m, 8 
H, crown O–CH2), 3.66 (m, 8 H, crown O–CH2), 3.57 (m, 4 H, crown O–CH2), 2.93 (m, 
2 H, PCH(CH3)2), 2.48 (m, 2 H, PCH(CH3)2), 1.42 (m, 6 H, PCH(CH3)2), 1.31 (m, 6 H, 
PCH(CH3)2), 0.96 (m, 6 H, PCH(CH3)2), 0.90 (m, 6 H, PCH(CH3)2). 31P NMR (121 
MHz, CD3CN , 25 °C), δ(ppm): 51.42 (s). 13C NMR (126 MHz, CD3CN , 25 °C), 
δ(ppm): 229.15 (t, 10 Hz, Mo-CO), 216.66 (t, 10 Hz, Mo-CO), 211.78 (t, 10 Hz, Mo-
CO), 149.80 (s, Ar-C1), 148.65 (s, crown Ar-C–O), 133.03 (s, Ar-CH), 132.29 (s, Ar-
CH), 131.73 (s, Ar-CH), 130.73 (s, Ar-CH), 128.59 (s, Ar-CH), 126.62 (s, Ar-CH), 
124.95 (s, Ar-CH), 122.43 (s, crown Ar-CH), 120.19 (s, Ar-C), 114.32 (s, crown Ar-CH), 
86.58 (s, C3), 69.49 (s, crown O–CH2), 68.75 (s, crown O–CH2), 68.26 (s, crown O–
CH2), 67.91 (s, crown O–CH2), 34.65 (t, PCH(CH3)2), 31.16 (t, PCH(CH3)2),  20.31 (t, 
PCH(CH3)2), 19.92 (t, PCH(CH3)2), 19.53 (s, PCH(CH3)2), 19.52 (s, PCH(CH3)2). IR 
(THF), νCO (cm-1): 1875, 1605. Anal. Calcd for [9], C61H79KMoO15P2: C, 58.65; H, 6.37. 
Found: C, 57.33; H, 6.10. 
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Synthesis of bis(benzo-15-crown-5)potassium [1,4-bis(2-bromophenyl)-2,3-
semicatecholate] (10) 
 
 
 
To a solution of 8 (0.0998 g, 0.238 mmol) in THF (2 mL) was added dropwise a solution 
of BnK (0.0309 g, 0.237 mmol) in THF (2 mL). Upon complete addition, a solution of 
benzo-15-crown-5 (0.1351 g, 0.504 mmol) in THF (2 mL) and the mixture was stirred at 
room temperature for 30 minutes. The volatiles were then removed under reduced 
pressure, and the resulting residue was triturated with Et2O (5 mL) and the solid collected 
on a pad of celite. The solid was then dissolved in benzene (5 mL), filtered through celite, 
and concentrated in vacuo to afford the desired product as an orange powder (0.1213, 
51%). 1H NMR (300 MHz, CD3CN , 25 °C), δ(ppm): 9.22 (s, br, 1 H, O–H), 8.04 (d, 8 
Hz, 2 H, Ar-CH), 7.91 (d, 8 Hz, 2 H, Ar-CH), 7.38 (t, 8 Hz, 2 H, Ar-CH), 7.25 (t, 8 Hz, 2 
H, Ar-CH), 6.91 (m, 2 H, crown Ar-CH), 6.81 (m, 2 H, crown Ar-CH), 5.38 (t, 4.9 Hz, 2 
H, quinonoid Ar-C3H), 3.91 (m, 4 H, crown O–CH2), 3.66 (m, 8 H, crown O–CH2), 3.66 
(m, 8 H, crown O–CH2), 3.57 (m, 4 H, crown O–CH2), 2.93 (m, 2 H, PCH(CH3)2), 2.48 
(m, 2 H, PCH(CH3)2), 1.42 (m, 6 H, PCH(CH3)2), 1.31 (m, 6 H, PCH(CH3)2), 0.96 (m, 6 
H, PCH(CH3)2), 0.90 (m, 6 H, PCH(CH3)2). 31P NMR (121 MHz, CD3CN , 25 °C), 
δ(ppm): 51.42 (s). 13C NMR (126 MHz, CD3CN , 25 °C), δ(ppm): 228.21 (t, 10 Hz, Mo-
CO), 215.71 (t, 10 Hz, Mo-CO), 210.83 (t, 10 Hz, Mo-CO), 148.86 (s, Ar-C1), 147.70 (s, 
crown Ar-C–O), 132.09 (m), 131.35 (s, Ar-CH), 130.79 (s, Ar-CH), 129.78 (s, Ar-CH), 
127.64 (s, Ar-CH), 125.68 (s, Ar-CH), 124.00 (s, Ar-CH), 121.48 (s, crown Ar-CH), 
113.37 (s, crown Ar-CH), 85.63 (s, C3), 68.55 (s, crown O–CH2), 67.81 (s, crown O–
CH2), 67.32 (s, crown O–CH2), 66.96 (s, crown O–CH2), 33.70 (t, PCH(CH3)2), 30.22 (t, 
PCH(CH3)2),  19.37 (t, PCH(CH3)2), 18.98 (t, PCH(CH3)2), 18.58 (s, PCH(CH3)2), 18.57 
(s, PCH(CH3)2). Anal. Calcd for [3], C46H51Br2KO12: C, 55.54; H, 5.17. Found: C, 54.15; 
H, 5.33. 
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Synthesis of 3,6-bis(2-bromophenyl)-1,2-benzoquinone (11) 
 
 
 
A round bottom flask was charged with 8 (200 mg, 0.476 mmol) dissolved in CH2Cl2 (40 
mL). Silver carbonate on Celite (2.23 g, 3.90 mmol, 1.75 mmol Ag2CO3/g) was added 
with stirring. The reaction was allowed to stir for 30 minutes at room temperature. The 
reaction was then filtered over a pad of Celite and the filtrate concentrated in vacuo to 
yield a red-orange solid (198 mg, 99%). 1H NMR (300 MHz, CDCl3 , 25 °C), δ(ppm): 
7.72 – 7.61 (m, 2 H, Ar-CH), 7.43 – 7.24 (m, 6 H, Ar-CH), 7.13 (s, 2 H, Ar-C3H). 13C 
NMR (126 MHz, CD3CN , 25 °C), δ(ppm): 178.27 (s, Ar-C=O), 142.26 (s, Ar-C), 137.96 
(s, Ar-C3H), 134.87 (s, Ar-C), 133.10 (s, Ar-CH), 131.02 (s, Ar-CH), 130.50 (s, Ar-CH), 
127.41 (s, Ar-CH), 123.15 (s, Ar-C). MS (m/z): calcd, 417.9027 [M]+; found, 417.9023 
(FAB+, [M]+). 
  
Ag2CO3 on Celite
CH2Cl2
8
Br Br
HO OH
Br Br
O O
11
	 	 S7 
General procedure for determining the pKa of compounds 1, 2, 3 and 8 
 
The pKa values for compounds 1, 2, 3, and 8 were determined via 1H NMR spectroscopy 
and are the average of triplicate self-consistent trials, as has been described previously. 
The compound of interest was combined with an acid or base of known pKa and the 
equilibrium populations were determined via 1H NMR spectroscopy. All compounds 
exhibit rapid proton exchange on the NMR time-scale, such that the chemical shift can be 
used to determine the mole fraction of the species in solution via the equation χA = (δeq – 
δA)/(δA – δB), where χA is mole fraction of the acid, δe is the equilibrium chemical shift 
and δA and δB are the chemical shifts of the pure acid and the pure conjugate base, 
respectively. The value of χA was determined using well-resolved 1H NMR signals, with 
good agreement observed between the independent calculations. The value used to 
determine the equilibrium concentration was the average of the independent caluclations. 
Once the equilibrium concentrations were determined, the equilibrium constant between 
the compound of interest and the acid/base of known pKa was determined, and by using 
Hess’s law the pKa of the Mo complex (or 8) was determined. The following acids/bases 
were used to determine the unknown pKa’s: 4-tert-butylphenol (pKa = 27.45) for 
compound 1 and 8; [2,2,2]-diazobicyclooctane (pKa = 18.60) for compound 3; 2-
nitroaniline (pKa = 4.80) for compound 2. Representative 1H NMR spectra of equilibrium 
mixtures used to calculate pKa’s are given in Figure S27. 
 
 
 
Reactions of 1, 2 and 8 with TEMPO and 11 with TEMPOH 
 
1 and TEMPO: Compound 1 (0.0295 g, 0.0437 mmol) and TEMPO (0.0147 g, 0.0941 
mmol) were combined in CD3CN (0.6 mL) in a 1 dram vial and thoroughly mixed for 30 
seconds until all of 1 had solubilized and the color had darkened from pale orange to red-
orange. The solution was then transferred to an NMR tube and the 1H and 31P NMR 
spectra were recorded (Figure S23). 
 
 
2 and TEMPO: Compound 2 (0.0225 g, 0.0238 mmol) and TEMPO (0.0082 g, 0.0525 
mmol) were combined in CD3CN (0.6 mL) in a 1 dram vial and thoroughly mixed for 30 
seconds until all of 2 had solubilized and the color had darkened from pale orange to red-
orange. The solution was then transferred to an NMR tube and the 1H and 31P NMR 
spectra were recorded (Figure S24). 
 
 
8 and TEMPO: Compound 8 (0.0412 g, 0.0981 mmol) and TEMPO (0.0299 g, 0.191 
mmol) were combined in CD3CN (0.6 mL) in a 1 dram vial and thoroughly mixed for 30 
seconds until all of 8 had solubilized. No color change was observed. The solution was 
then transferred to an NMR tube and the 1H and 31P NMR spectra were recorded (Figure 
S25). 
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11 and TEMPOH: Compound 11 (0.0100 g, 0.0239 mmol) and TEMPOH (0.0075 g, 
0.0477 mmol) were combined in CD3CN (0.6 mL) in a 1 dram vial and thoroughly mixed 
for 30 seconds until all of 11 had solubilized. The solution was then transferred to an 
NMR tube and the 1H and 31P NMR spectra were recorded, showing generation of 
compound 8 (Figure S26). The solution turned from a red orange to a pale pink within 
minutes. 
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II. Nuclear Magnetic Resonance Spectra 
 
 
 Figure S1. 1H NMR spectrum of 2 in CD3CN at 25 °C.	
 
 
Figure S2. 13C{1H} NMR spectrum of 2 in CD3CN at 25 °C.	
 
 
 Figure S3. 31P{1H} NMR spectrum of 2 in CD3CN at 25 °C. 
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Figure S4. 19F NMR spectrum of 2 in CD3CN at 25 °C. 
 
 
Figure S5. 1H NMR spectrum of 3 in CD3CN at 25 °C.	
 
 
Figure S6. 13C{1H} NMR spectrum of 3 in CD3CN at 25 °C. 
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Figure S7. 31P{1H} NMR spectrum of 3 in CD3CN at 25 °C.	
 
 
Figure S8. 19F NMR spectrum of 3 in CD3CN at 25 °C.	
 
 
Figure S9. 1H NMR spectrum of mixture of 5a and 5b in CD3CN at 25 °C. 
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Figure S10. 13C{1H} NMR spectrum of mixture of 5a and 5b in CD3CN at 25 °C.	
 
 
Figure S11. 31P{1H} NMR spectrum of mixture of 5a and 5b in CD3CN at 25 °C.	
 
 
Figure S12. 19F NMR spectrum of mixture of 5a and 5b in CD3CN at 25 °C. 
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Figure S13. 1H NMR spectrum of 6 in CD2Cl2 at 25 °C.	
 
 
Figure S14. 13C{1H} NMR spectrum of 6 in CD2Cl2 at 25 °C.	
 
 
 Figure S15. 31P{1H} NMR spectrum of 6 in CD2Cl2 at 25 °C. 
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Figure S16. 1H NMR spectrum of 9 in CD3CN at 25 °C. 
 
 
Figure S17. 13C{1H} NMR spectrum of 9 in CD3CN at 25 °C.	
 
 
 Figure S18. 31P{1H} NMR spectrum of 9 in CD3CN at 25 °C.	
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Figure S19. 1H NMR spectrum of 10 in CD3CN at 25 °C. 
 
 
 
Figure S20. 13C NMR spectrum of 10 in CD3CN at 25 °C. 
 
 
 
Figure S21. 1H NMR spectrum of 11 in CDCl3 at 25 °C. 
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Figure S22. 13C NMR spectrum of 11 in CDCl3 at 25 °C. 
 
 
  
Figure S23. 1H NMR spectrum (left) and 31P NMR spectrum (right) of 1 and 2 equiv. 
TEMPO in CD3CN at 25 °C after 10 min. 
 
 
 
Figure S24. 1H NMR spectrum (left) and 31P NMR spectrum (right) of 2 and 2 equiv. 
TEMPO in CD3CN at 25 °C after 10 min. 
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Figure S25. 1H NMR spectrum of 8 and 2 equiv. TEMPO in CD3CN at 25 °C after 10 
min. 
 
 
 
Figure S26. 1H NMR spectrum of 11 and 2 equiv. TEMPOH in CD3CN at 25 °C after 10 
min. 
 
 
 
Figure S27. Representative 1H NMR spectrum of equilibrium mixtures in CD3CN of 9 
and 4-tBuPhOH (brown), 2 and 2-NO2PhNH2 (green), 3 and DABCO (teal), and 10 and 
4-tBuPhOH (purple) all recorded at 25 °C. 
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III. Estimation of O-H BDFE 
 
Table S1. Thermochemical data for selected quinonoid compounds. Note that 1, 2, and 3 
show irreversible redox events by cyclic voltammetry. 
 pKa(O–H)a E°Irr(O-/O·)b Estimated BDFEO–Hc 
1 25.89(9) -0.770 V 73 kcal/mol 
2 4.74(9) 0.220 V 67 kcal/mol 
3 17.1(4) -0.470 V 68 kcal/mol 
8 26.3(1) -0.630 Vd 76 kcal/mol 
apKa for first O–H determined via solution equilibria (see SI). bIrreversible oxidation 
potential for conjugate base determined via square-wave voltammetry. cCalculated using 
equation (1). dReversible oxidation  event. 
 
 
IV. Crystallographic Information 
 
CCDC 1469761-1469764 contain the supplementary crystallographic data for this paper. 
These data can be obtained free of charge from The Cambridge Crystallographic Data 
Centre via www.ccdc.cam.ac.uk/data_request/cif.  
 
Refinement Details  
In each case, crystals were mounted on a glass fiber or nylon loop using Paratone oil, 
then placed on the diffractometer under a nitrogen stream. Low temperature (100 K) X-
ray data were obtained on a Bruker APEXII CCD based diffractometer (Mo sealed X-ray 
tube, Kα = 0.71073 Å) or a Bruker PHOTON100 CMOS based diffractometer (Mo micro-
focus sealed X-ray tube, Kα = 0.71073 Å). All diffractometer manipulations, including 
data collection, integration, and scaling were carried out using the Bruker APEXII 
software.6 Absorption corrections were applied using SADABS.7 Space groups were 
determined on the basis of systematic absences and intensity statistics and the structures 
were solved by direct methods using XS8, by intrinsic phasing using XT (incorporated 
into SHELXTL), or by charge flipping using Olex29 and refined by full-matrix least 
squares on F2. All non-hydrogen atoms were refined using anisotropic displacement 
parameters. Hydrogen atoms were placed in the idealized positions and refined using a 
riding model. The structures were refined (weighed least squares refinement on F2) to 
convergence. Graphical representation of structures with 50% probability thermal 
ellipsoids was generated using Diamond visualization software.10 
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Table S2. Crystal and refinement data for 3, 5a•2NCMe, 5b, and  6. 
Compound 3 5a•2NCMe 5b 6 
CCDC 1469761 1469762 1469763 1469764 
empirical formula C33H39F3MoO7P2S C39H50F12MoN4O3P2Sb2 C37H44F6MoN2O9P2S2 C31H38Cl2MoO3P2 
formula wt 794.61 g/mol 1252.23 g/mol 996.74 g/mol 687.39 g/mol 
T (K) 100 100 100 100 
a, Å 30.285(3) 10.005(1) 11.3464(4) 16.255(1) 
b, Å 26.445(2) 27.668(2) 21.2519(8) 16.255(1) 
c, Å 17.945(1) 19.306(1) 17.4117(7) 22.205(2) 
α, deg 90 90 90 90 
β, deg 93.729(2) 94.925(3) 94.171(1) 90 
γ, deg 90 90 90 90 
V, Å3 14341(2) 5324.3(5) 4187.4(3) 5866.9(5) 
Z 4 4 4 8 
cryst syst Monoclinic Monoclinic Monoclinic Orthorhombic 
space group P21/c P21/n P21/n Pbca 
dcalc, g/cm3 1.407 1.562 1.581 1.556 
θ range, deg 2.18-33.14 1.29-38.57 2.629-43.71 1.83-45.29 
µ , mm-1 0.573 1.377 0.571 0.771 
abs cor Semi-empirical Semi-empirical Semi-empirical Semi-empirical 
GOF 1.070 1.132 1.058 0.954 
R1a, wR2b (I > 
2sig(I)) 
0.0556, 0.1313 0.0409, 0.1502 0.0317, 0.0756 0.0338, 0.0868 
Diffractometer APEXII APEXII PHOTON100 APEXII 
a R1 = Σ||Fo| - |Fc||/Σ|Fo|. b wR2 = [Σ[w(Fo2 – Fc2)2]/ Σ[w(Fo2)2]]1/2
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Figure S28. Structural drawing of 3 with 50% probability ellipsoids. Hydrogen atoms, 
and additional three Mo complexes and three triflate anions of the asymmetric unit are 
omitted for clarity. Carbon and fluorine atoms are shown in black and green, respectively. 
 
Special Refinement Details for 3: One of the four triflate anions was positionally 
disordered and satisfactorily modeled as approximately a 50:50 mixture using “PART”, 
“SAME”, and “EADP” cards in SHELX. Two isopropyl groups were also positionally 
disordered and satisfactorily modeled as approximately 70:30 mixtures using “PART” 
cards in SHELX. Two DMF solvent molecules were highly disordered and could not be 
adequately modeled even with constraints. The electron density of these molecules was 
removed using the “solvent mask” function in Olex2. 
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Figure S29. Structural drawing of 5a•2NCMe with 50% probability ellipsoids. 
Hydrogen atoms and solvent molecules are omitted for clarity. Carbon and fluorine atoms 
are shown in black and green, respectively. 
 
Special Refinement Details for 5a: Two acetonitrile solvent molecules were highly 
disordered and could not be adequately modeled even with constraints. The electron 
density of these molecules was removed using the “solvent mask” function in Olex2. 
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Figure S30. Structural drawing of 5b with 50% probability ellipsoids. Hydrogen atoms 
are omitted for clarity. Carbon and fluorine atoms are shown in black and green, 
respectively. 
 
 
Figure S31. Structural drawing of 6 with 50% probability ellipsoids. Hydrogen atoms are 
omitted for clarity. Carbon atoms are shown in black. 
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